Blueberries Medical Corp. (CNSX: BBM)
Health Care · Pharmaceuticals · CA
CA$0.02
-25.00% today · 0.0% 1Y
Blueberries Medical Corp. (CNSX: BBM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.39M and employs 51 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.01 and 0.02.
Tweenvest scores Blueberries Medical Corp. across four factors: quality 15/100, value 60/100, growth 100/100. Its strongest factor is growth.
BBM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.39M
- Revenue (TTM)
- $214.78K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 2.64
- 52-week high
- CA$0.02
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 495.09M
- Employees
- 51
- Next earnings
- —
About Blueberries Medical Corp.
Headquartered in Bogotá, Colombia, Blueberries Medical Corp. operates within the medicinal cannabis industry. The company's activities encompass the entire process, from cultivating and developing to producing and supplying medical-grade cannabis and its associated products across Colombia. Their offerings notably include medicinal cannabis oil extracts and other complementary items.
- ISIN
- CA09609Y1016
- Listed since
- Apr 9, 2014
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.16 | +0.34% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.18 | -0.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.23% |
Figures last refreshed Aug 18, 2026.